Nxera Pharma Co., Ltd. (SOLTF)
OTCMKTS · Delayed Price · Currency is USD
5.44
0.00 (0.00%)
Feb 11, 2026, 9:30 AM EST
Nxera Pharma Market Cap
Nxera Pharma has a market cap or net worth of $517.09 million as of February 12, 2026. Its market cap has decreased by -4.57% in one year.
Market Cap
517.09M
Enterprise Value
743.29M
Revenue
193.93M
Ranking
n/a
PE Ratio
n/a
Stock Price
$5.44
Market Cap Chart
Since July 29, 2004, Nxera Pharma's market cap has increased from 343.19M to 517.09M, an increase of 50.67%. That is a compound annual growth rate of 1.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 521.12M | 8.82% |
| Dec 30, 2025 | 478.89M | -20.11% |
| Dec 30, 2024 | 599.46M | -33.52% |
| Dec 29, 2023 | 901.69M | -32.11% |
| Dec 30, 2022 | 1.33B | -1.47% |
| Dec 30, 2021 | 1.35B | -4.00% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 399.44M |
| CytoDyn | 311.51M |
| Silence Therapeutics | 211.61M |
| Vaxart | 145.24M |
| HST Global | 139.70M |
| BioStem Technologies | 105.50M |
| Nuo Therapeutics | 76.77M |
| VitaSpring Biomedical | 51.78M |